{"url":"https://lda.gov/api/v1/filings/b4a8e6b7-8251-41be-bd83-13f7ff95e461/","filing_uuid":"b4a8e6b7-8251-41be-bd83-13f7ff95e461","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b4a8e6b7-8251-41be-bd83-13f7ff95e461/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2026-07-20T18:55:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th FL","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":196591,"url":"https://lda.gov/api/v1/clients/196591/","client_id":874,"name":"INDEPENDENT PHARMACY COOPERATIVE","general_description":"Largest group purchasing organization for independent pharmacies.","client_government_entity":false,"client_self_select":null,"state":"WI","state_display":"Wisconsin","country":"US","country_display":"United States of America","ppb_state":"WI","ppb_state_display":"Wisconsin","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57908,"prefix":"mr","prefix_display":"MR.","first_name":"JERRY","nickname":"JAY","middle_name":null,"last_name":"DRISCOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57908,"prefix":"mr","prefix_display":"MR.","first_name":"JERRY","nickname":"JAY","middle_name":null,"last_name":"DRISCOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57908,"prefix":"mr","prefix_display":"MR.","first_name":"JERRY","nickname":"JAY","middle_name":null,"last_name":"DRISCOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation Program in the One Big Beautiful Bill Act (P.L. 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57908,"prefix":"mr","prefix_display":"MR.","first_name":"JERRY","nickname":"JAY","middle_name":null,"last_name":"DRISCOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Issues related to S.3822 - Break Up Big Medicine Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57908,"prefix":"mr","prefix_display":"MR.","first_name":"JERRY","nickname":"JAY","middle_name":null,"last_name":"DRISCOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}